Answers are grounded in this paper and cite their sources.
Cohort study demonstrates pre-frailty and frailty independently predict increased mortality in breast cancer survivors, indicating the need for routine screening and targeted interventions.
Frailty is increasingly recognized as a determinant of poor outcomes in cancer survivorship, yet its prognostic value among breast cancer survivors remains unclear, particularly for pre-frailty. We analyzed data from 22 waves of the national health interview survey (1997–2018), linked to the national death index, encompassing 625,128 adults, including 9941 breast cancer survivors and 615,187 cancer-free participants. Frailty was assessed using a modified fatigue, resistance, ambulation, illness, and loss of weight scale and categorized as robust (score 0), pre-frail (score 1–2), or frail (score 3–5). Kaplan–Meier methods and log-rank tests evaluated survival differences, and Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause mortality, adjusting for sociodemographic, clinical, and cancer-related covariates. Among breast cancer survivors, 78.3% were robust, 13.1% pre-frail, and 8.6% frail, compared with 88.7%, 6.3%, and 5.0% among cancer-free participants. Kaplan–Meier analyses revealed significant survival differences across frailty categories (log-rank P < .001). In fully adjusted models, pre-frailty (HR, 1.44; 95% CI, 1.39–1.51) and frailty (HR, 1.70; 95% CI, 1.49–1.94) were both independently associated with increased mortality relative to robust survivors. Associations were consistent in women and in survivors aged ≥60 years. Among survivors younger than 60 years, frailty remained a strong predictor of mortality (HR, 2.46; 95% CI, 1.52–4.00), whereas pre-frailty did not reach statistical significance. In the small subgroup of male survivors, frailty was not significantly associated with mortality, likely due to limited sample size. Both pre-frailty and frailty independently predict mortality in breast cancer survivors. Systematic frailty screening and targeted interventions may improve survivorship outcomes.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: